Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Teva
Cipla
US Army
Medtronic
Fuji
UBS
Mallinckrodt
Citi

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,968,976

« Back to Dashboard

Which drugs does patent 5,968,976 protect, and when does it expire?

Patent 5,968,976 protects FOSRENOL and is included in two NDAs.

This patent has thirty-five patent family members in twenty-seven countries.
Summary for Patent: 5,968,976
Title: Pharmaceutical composition containing selected lanthanum carbonate hydrates
Abstract:Selected lanthanum carbonate hydrates may be administered into the gastrointestinal tract, to treat hyperphosphataemia in patients with renal failure.
Inventor(s): Murrer; Barry A (Berkshire, GB), Powell; Nigel A (Berkshire, GB)
Assignee: AnorMed Inc. (Langley, CA)
Application Number:08/913,960
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Dosage form; Process; Formulation;

Drugs Protected by US Patent 5,968,976

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Shire Dev Llc FOSRENOL lanthanum carbonate POWDER;ORAL 204734-002 Sep 24, 2014 RX Yes Yes ➤ Sign Up ➤ Sign Up Y TO REDUCE SERUM PHOSPHATE IN PATIENTS WITH END STAGE RENAL DISEASE ➤ Sign Up
Shire Dev Llc FOSRENOL lanthanum carbonate POWDER;ORAL 204734-001 Sep 24, 2014 RX Yes No ➤ Sign Up ➤ Sign Up Y TO REDUCE SERUM PHOSPHATE IN PATIENTS WITH END STAGE RENAL DISEASE ➤ Sign Up
Shire Llc FOSRENOL lanthanum carbonate TABLET, CHEWABLE;ORAL 021468-004 Nov 23, 2005 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y REDUCTION OF SERUM PHOSPHATE ➤ Sign Up
Shire Llc FOSRENOL lanthanum carbonate TABLET, CHEWABLE;ORAL 021468-001 Oct 26, 2004 DISCN No No ➤ Sign Up ➤ Sign Up Y REDUCTION OF SERUM PHOSPHATE ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,968,976

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9506126Mar 25, 1995
PCT Information
PCT FiledMarch 19, 1996PCT Application Number:PCT/GB96/00575
PCT Publication Date:October 03, 1996PCT Publication Number: WO96/30029

International Patents Family Members for US Patent 5,968,976

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 0817639 ➤ Sign Up SPC/GB06/036 United Kingdom ➤ Sign Up
European Patent Office 0817639 ➤ Sign Up PA2008005 Lithuania ➤ Sign Up
European Patent Office 0817639 ➤ Sign Up PA2008005,C0817639 Lithuania ➤ Sign Up
Estonia 04096 ➤ Sign Up
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Dow
Accenture
Express Scripts
Farmers Insurance
Argus Health
Medtronic
McKesson
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.